首页 | 本学科首页   官方微博 | 高级检索  
检索        

脂多糖/Toll样受体4信号转导与肝纤维化的研究进展
引用本文:朱晓静,张峰,孔德松,陆茵,王爱云,陈文星,郑仕中.脂多糖/Toll样受体4信号转导与肝纤维化的研究进展[J].中国药理学与毒理学杂志,2013,27(1):106-109.
作者姓名:朱晓静  张峰  孔德松  陆茵  王爱云  陈文星  郑仕中
作者单位:1. 南京中医药大学药学院江苏省中药药效与安全性评价重点实验室, 江苏 南京 210046;;2. 南京中医药大学中药学一级学科, 江苏 南京 210046
基金项目:国家自然科学基金资助项目(30873424);国家自然科学基金资助项目(81270514);国家十一五支撑计划项目(2008BAI51B02);南京中医药大学中药学一级学科开放课题项目(2011ZYX4-008);教育部博士点基金资助项目(20103237110010);江苏省自然科学基金资助项目(BK2008456);江苏省六大人才高峰资助项目(2009112);江苏高校优势学科建设工程资助项目(ysxk-2010);江苏省针灸学重点实验室开放课题(KJA200801)~~
摘    要:Toll样受体4(TLR4)是一种模式识别受体,能与革兰阴性细菌细胞壁的主要成分脂多糖结合,启动天然免疫反应和获得性免疫反应,有效对抗病原微生物的感染。肝中所有实质细胞和非实质细胞都能表达TLR4。近年来,越来越多的研究表明,肝中的一些细胞如肝星状细胞、枯否细胞和树突状细胞等能通过各自表面的脂多糖/TLR4信号转导途径,释放多种细胞因子,引起一系列病理变化,共同参与肝纤维化的发生和发展过程。本文就对脂多糖/Toll样受体4信号转导与肝纤维化的研究进展作一综述。

关 键 词:Toll样受体4  脂多糖  信号转导  肝纤维化
收稿时间:2012-3-21
修稿时间:2012-7-17

Progress in lipopolysaccharide/Toll-like receptor 4 signaling transduction in hepatic fibrosis
ZHU Xiao-jing,, ZHANG Feng,, KONG De-song,, LU Yin,, WANG Ai-yun,, CHEN Wen-xing,, ZHENG Shi-zhong,.Progress in lipopolysaccharide/Toll-like receptor 4 signaling transduction in hepatic fibrosis[J].Chinese Journal of Pharmacology and Toxicology,2013,27(1):106-109.
Authors:ZHU Xiao-jing    ZHANG Feng    KONG De-song    LU Yin    WANG Ai-yun    CHEN Wen-xing    ZHENG Shi-zhong  
Institution:1. Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210046, China;2. National First-Class Key Discipline for Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210046, China
Abstract:Toll-like receptor 4(TLR4) is one of the pattern recognition receptors. It acts as a receptor for lipopolysaccharide, a cell-wall component of Gram-negative bacteria. The innate and adaptive immune responses are initiated by lipopolysaccharide binding to TLR4 so as to effectively reduce microorganism invasion. In the liver, all parenchyma cells and nonparenchymal cells can express TLR4. In recent years, there is growing evidence that some cells in the liver, such as hepatic stellate cells, Kupffer cells and dendritic cells, can release many kinds of cytokines through lipopolysaccharide/TLR4 signal transduction, causeing a series of pathological changes so as to participate in the pathogenesis of hepatic fibrosis.
Keywords:Toll-like receptor 4  lipopolysaccharide  signaling transduction  hepatic fibrosis  hepatic stellate cells  Kupffer cells
本文献已被 CNKI 等数据库收录!
点击此处可从《中国药理学与毒理学杂志》浏览原始摘要信息
点击此处可从《中国药理学与毒理学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号